← Back to Search

Neurostimulation Device

Nalu SCS System for Pain (nPower™-US Trial)

N/A
Waitlist Available
Research Sponsored by Nalu Medical, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights
No Placebo-Only Group

Summary

This trial tests a small device that sends electrical signals to reduce chronic leg and back pain in adults who still have pain after back surgery. The device works by changing how pain signals are sent to the brain. This method has been shown to be effective in reducing leg and back pain, especially in patients who have not found relief from previous back surgeries.

Eligible Conditions
  • Pain
  • Chronic Pain
  • Back Pain

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Responders at 3-months

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Nalu SCS SystemExperimental Treatment1 Intervention
All eligible subjects will receive the Nalu Neurostimulation System
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Nalu Neurostimulation System
2020
N/A
~110

Find a Location

Who is running the clinical trial?

Nalu Medical, Inc.Lead Sponsor
2 Previous Clinical Trials
274 Total Patients Enrolled
JIm Makous, PhDStudy DirectorNalu Medical, Inc.
Patrick MartinStudy DirectorNalu Medical
2 Previous Clinical Trials
274 Total Patients Enrolled
~21 spots leftby Nov 2025